Chris Lane

Chris Lane is a Clinical Science Lead at Roche, where they focus on late-stage studies in Alzheimer's disease. With extensive clinical and research experience, they have previously held several positions at Roche, including Clinical Director in Neuroscience clinical development. Chris completed a PhD in Neuroscience at UCL, investigating vascular risk factors and their effects on brain pathology. Their early career included roles at various NHS trusts and as a Clinical Research Associate at UCL, contributing to important clinical trials and studies in the field.